Assessment of pulmonary infectious disease treatment with Mongolian medicine formulae based on data mining, network pharmacology and molecular docking

OBJECTIVE: Pulmonary infectious diseases (PID) include viral pneumonia (VP) and pulmonary tuberculosis (PT). Mongolian medicine (MM) is an effective treatment option in China, however, the core group medicines (CGMs) in the treatment of PID and their underlying therapeutic mechanisms remain unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Baochang, Qian, Zhanhong, Li, Qinyu, Gao, Yuan, Li, Minhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476772/
https://www.ncbi.nlm.nih.gov/pubmed/36118001
http://dx.doi.org/10.1016/j.chmed.2022.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476772/
https://www.ncbi.nlm.nih.gov/pubmed/36118001
http://dx.doi.org/10.1016/j.chmed.2022.07.001

Ejemplares similares